• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[结直肠癌炎症蛋白标志物的遗传驱动因素:临床预后研究的孟德尔随机化方法]

[Genetic drivers for inflammatory protein markers in colorectal cancer: a Mendelian randomization approach to clinical prognosis study].

作者信息

Li H, Li G, Zhang X, Wang Y

机构信息

Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 511340, China.

出版信息

Nan Fang Yi Ke Da Xue Xue Bao. 2024 Jul 20;44(7):1361-1369. doi: 10.12122/j.issn.1673-4254.2024.07.16.

DOI:10.12122/j.issn.1673-4254.2024.07.16
PMID:39051082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11270664/
Abstract

OBJECTIVE

To explore the causal relationship between inflammatory protein markers and the risk of colorectal cancer using a Mendelian randomization (MR) approach.

METHODS

We obtained data pertaining to colorectal cancer from Genome-Wide Association Study (GWAS) datasets and used 91 inflammatory protein markers as the exposure variables. A two-sample MR analysis model was used to assess the causal link between the inflammatory markers and colorectal cancer risk. The robustness of the results was evaluated through heterogeneity, pleiotropy, and sensitivity analyses using 5 MR models: Inverse Variance Weighted (IVW), Weighted Median, MR Egger, Simple Mode, and Weighted Mode. We examined the mRNA expressions of -, , and - using RT-qPCR in 86 untreated patients with colorectal adenocarcinoma admitted in Nanfang Hospital between December, 2021 and December 2023, and analyzed their correlation with the clinical characteristics of the patients.

RESULTS

Using the IVW model, MR analysis revealed significant causal associations between a reduced risk of colorectal cancer and lowered expressions of AXIN1 (OR=0.866, 95% : 0.754-0.994, =0.040), β-NGF (OR=0.914, 95% : 0.843-0.990, =0.028; OR=0.884, 95% : 0.784-0.998, =0.047 using Weighted Median model), and PD-L1 (OR=0.903, 95% : 0.824- 0.989, =0.028). No significant heterogeneity or pleiotropy was observed, indicating good stability of the results. Sensitivity analysis confirmed the reliability of the findings. The clinical study demonstrated a significant correlation between PD-L1 expression and TNM staging, particularly in stage Ⅳ patients (=0.007). AXIN1 and β -NGF expression levels were significantly correlated with the degree of tumor differentiation, and their expressions were higher in poorly differentiated samples (<0.001).

CONCLUSION

Lowered expressions of inflammatory protein markers AXIN1, β-NGF, and PD-L1 are causally correlated with a reduced risk of colorectal cancer and their expression levels are associated with TNM staging and tumor differentiation. These markers may thus serve as potential targets for colorectal cancer treatment and prevention.

摘要

目的

采用孟德尔随机化(MR)方法探讨炎症蛋白标志物与结直肠癌风险之间的因果关系。

方法

我们从全基因组关联研究(GWAS)数据集中获取了结直肠癌相关数据,并使用91种炎症蛋白标志物作为暴露变量。采用两样本MR分析模型评估炎症标志物与结直肠癌风险之间的因果联系。通过使用5种MR模型(逆方差加权法(IVW)、加权中位数法、MR-Egger法、简单模式法和加权模式法)进行异质性、多效性和敏感性分析来评估结果的稳健性。我们使用RT-qPCR检测了2021年12月至2023年12月期间在南方医院收治的86例未经治疗的结直肠腺癌患者中-、-和-的mRNA表达,并分析了它们与患者临床特征的相关性。

结果

使用IVW模型,MR分析显示结直肠癌风险降低与AXIN1表达降低(OR=0.866,95%可信区间:0.754-0.994,P=0.040)、β-NGF表达降低(OR=0.914,95%可信区间:0.843-0.990,P=0.028;使用加权中位数模型时OR=0.884,95%可信区间:0.784-0.998,P=0.047)以及PD-L1表达降低(OR=0.903,95%可信区间:0.824-0.989,P=0.028)之间存在显著的因果关联。未观察到显著的异质性或多效性,表明结果具有良好的稳定性。敏感性分析证实了研究结果的可靠性。临床研究表明PD-L1表达与TNM分期之间存在显著相关性,尤其是在Ⅳ期患者中(P=0.007)。AXIN1和β-NGF表达水平与肿瘤分化程度显著相关,且在低分化样本中表达较高(P<0.001)。

结论

炎症蛋白标志物AXIN1、β-NGF和PD-L1表达降低与结直肠癌风险降低存在因果关联,且它们的表达水平与TNM分期和肿瘤分化相关。因此,这些标志物可能作为结直肠癌治疗和预防的潜在靶点。

相似文献

1
[Genetic drivers for inflammatory protein markers in colorectal cancer: a Mendelian randomization approach to clinical prognosis study].[结直肠癌炎症蛋白标志物的遗传驱动因素:临床预后研究的孟德尔随机化方法]
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Jul 20;44(7):1361-1369. doi: 10.12122/j.issn.1673-4254.2024.07.16.
2
Causal associations between liver traits and Colorectal cancer: a Mendelian randomization study.肝脏特征与结直肠癌之间的因果关联:一项孟德尔随机化研究。
BMC Med Genomics. 2023 Dec 6;16(1):316. doi: 10.1186/s12920-023-01755-w.
3
[Genetic Causation Analysis of Hyperandrogenemia Testing Indicators and Preeclampsia].[高雄激素血症检测指标与子痫前期的遗传因果关系分析]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 May 20;55(3):566-573. doi: 10.12182/20240560106.
4
Mendelian randomization unraveled: gender-specific insights into obesity-related phenotypes and colorectal cancer susceptibility.孟德尔随机化揭示:肥胖相关表型和结直肠癌易感性的性别特异性见解。
Front Endocrinol (Lausanne). 2024 Jun 6;15:1322253. doi: 10.3389/fendo.2024.1322253. eCollection 2024.
5
Identification of host gene-microbiome associations in colorectal cancer patients using mendelian randomization.利用孟德尔随机化鉴定结直肠癌患者的宿主基因-微生物组关联。
J Transl Med. 2023 Aug 10;21(1):535. doi: 10.1186/s12967-023-04335-9.
6
Causal relationship between bone mineral density and intervertebral disc degeneration: a univariate and multivariable mendelian randomization study.骨密度与椎间盘退变之间的因果关系:单变量和多变量孟德尔随机化研究。
BMC Musculoskelet Disord. 2024 Jul 5;25(1):517. doi: 10.1186/s12891-024-07631-7.
7
Genetic causal relationship between age at menarche and benign oesophageal neoplasia identified by a Mendelian randomization study.基于孟德尔随机化研究的月经初潮年龄与良性食管肿瘤之间的遗传因果关系。
Front Endocrinol (Lausanne). 2023 Mar 21;14:1113765. doi: 10.3389/fendo.2023.1113765. eCollection 2023.
8
No evidence of genetic causal association between sex hormone-related traits and systemic lupus erythematosus: A two-sample Mendelian randomization study.没有证据表明性激素相关特征与系统性红斑狼疮之间存在遗传因果关系:一项两样本孟德尔随机化研究。
Clin Rheumatol. 2023 Dec;42(12):3237-3249. doi: 10.1007/s10067-023-06700-x. Epub 2023 Jul 26.
9
Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study.神经退行性疾病是否与炎症性肠病的风险增加有关?一项两样本孟德尔随机化研究。
Front Immunol. 2022 Sep 8;13:956005. doi: 10.3389/fimmu.2022.956005. eCollection 2022.
10
Plasma lipids, alcohol intake frequency and risk of Osteoarthritis: a Mendelian randomization study.血浆脂质、饮酒频率与骨关节炎风险:一项孟德尔随机研究。
BMC Public Health. 2023 Jul 11;23(1):1327. doi: 10.1186/s12889-023-16250-1.

本文引用的文献

1
Clinical implications of PD-L1 expression and pathway-related molecular subtypes in advanced Asian colorectal cancer patients.程序性死亡配体1(PD-L1)表达及通路相关分子亚型在晚期亚洲结直肠癌患者中的临床意义
Am J Cancer Res. 2024 Feb 15;14(2):796-808. doi: 10.62347/FSSF9938. eCollection 2024.
2
Nerve Growth Factor and the Role of Inflammation in Tumor Development.神经生长因子与炎症在肿瘤发展中的作用。
Curr Issues Mol Biol. 2024 Jan 23;46(2):965-989. doi: 10.3390/cimb46020062.
3
Mendelian randomization studies on coronary artery disease: a systematic review and meta-analysis.孟德尔随机化研究在冠状动脉疾病中的应用:系统综述和荟萃分析。
Syst Rev. 2024 Jan 16;13(1):29. doi: 10.1186/s13643-023-02442-8.
4
Identifying metabolic features of colorectal cancer liability using Mendelian randomization.利用孟德尔随机化鉴定结直肠癌易感性的代谢特征。
Elife. 2023 Dec 21;12:RP87894. doi: 10.7554/eLife.87894.
5
Colorectal Cancer Immunotherapy: State of the Art and Future Directions.结直肠癌免疫疗法:现状与未来方向。
Gastro Hep Adv. 2023;2(8):1103-1119. doi: 10.1016/j.gastha.2023.09.007. Epub 2023 Sep 19.
6
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.循环炎症蛋白的遗传学鉴定出了免疫介导疾病风险的驱动因素和治疗靶点。
Nat Immunol. 2023 Sep;24(9):1540-1551. doi: 10.1038/s41590-023-01588-w. Epub 2023 Aug 10.
7
Inverse relationship between amount and tumor CD274 (PD-L1) expression in colorectal carcinoma.结直肠癌中数量与肿瘤CD274(PD-L1)表达之间的负相关关系。
Clin Transl Immunology. 2023 Aug 2;12(8):e1453. doi: 10.1002/cti2.1453. eCollection 2023.
8
Special Issue "Current Management of Early and Advanced Rectal Cancer".特刊“早期和晚期直肠癌的当前管理”
Cancers (Basel). 2023 Jul 12;15(14):3574. doi: 10.3390/cancers15143574.
9
Incidence and Factors Associated With Mental Health Disorders in Patients With Rectal Cancer Post-Restorative Proctectomy.直肠癌根治性切除术后患者心理健康障碍的发生率及相关因素
Dis Colon Rectum. 2023 Sep 1;66(9):1203-1211. doi: 10.1097/DCR.0000000000002744. Epub 2023 Jun 29.
10
Rectal Cancer Management and the Long List of Unanswered Questions.
Ann Surg Oncol. 2023 Aug;30(8):4566-4567. doi: 10.1245/s10434-023-13577-2. Epub 2023 May 5.